Gut
bacteria control tumor growth via the mammalian immune system, according to the
following paper:
M.R.
Rutkowski et al., “Microbially driven TLR5-dependent signaling governs distal
malignant progression through tumor-promoting inflammation,” Cancer Cell, 27:27-40, 2015.
The
gut microbiome influences nonintestinal cancer progression, but the role of
toll-like receptor 5 (TLR5), an immune system protein that recognizes commensal
bacteria, was a mystery. As more than seven percent of people have nonfunctional
TLR5, José Conejo-Garcia of the Wistar Institute in Philadelphia and colleagues
explored how TLR5 impacts tumor growth.
Posted by Tim Sandle
No comments:
Post a Comment
Pharmaceutical Microbiology Resources